This site has just undergone scheduled maintenance in order to be moved to a new infrastructure. You shouldn’t experience any change, but do let us know (datacentre@scilifelab.se) if you think anything looks out of place.

Drug repurposing screens identify compounds that inhibit α-synuclein oligomers' membrane disruption and block antibody interactions

Somavarapu AK, Kleijwegt G, Nagaraj M, Alam P, Nielsen J, Otzen DE

Chem. Sci. 14 (11) 3030-3047 [2023-00-00; online 2023-00-00]

Chemical Biology Consortium Sweden (CBCS) [Service]

DOI 10.1039/d2sc05534a

Crossref 10.1039/d2sc05534a


Publications 9.5.1